Mitochondrial vulnerability and neurovasculature function connection impacts neuropsychiatric disease
In a new study led by Penn’s School of Veterinary Medicine and Children’s Hospital of Philadelphia, researchers have found that mitochondrial dysfunction in the blood-brain barrier may lead to neuropsychiatric disease in some patients with 22qDS. The researchers also demonstrate that a class of FDA-approved cholesterol drugs could potentially be repurposed to treat this dysfunction.
Helping robots work together to explore the Moon and Mars
Penn Engineers, NASA, and five other universities tested robotic systems designed to help unmanned explorers cooperate in the dunes of White Sands, New Mexico, paving the way for Moon and Mars exploration.
Future mRNA vaccines may prevent food and seasonal allergies
Early research from Penn Medicine finds a new mRNA vaccine stops allergens from causing immune reactions and life-threatening inflammation, with promise for future treatment for a variety of seasonal and food allergies.
Deepfakes, digital doubles, and the law: Jennifer Rothman on protecting identity in the AI era
The evolution of AI technology may require more robust copyright laws and guardrails that protect people’s control of their own identities, says the Penn Carey Law professor.
